Breast Cancer: Targets and Therapy

Qualis

• A3

código do país

• NZ

tipo

• journal

publicação venue de

• Exploring Real-World HER2-Low Data in Early-Stage Triple-Negative Breast Cancer: Insights and Implications.  Volume 15:337-347. 2023-01-01
• Analysis of Increased EGFR and IGF-1R Signaling and Its Correlation with Socio-Epidemiological Features and Biological Profile in Breast Cancer Patients: A Study in Northern Brazil.  2021:325-339. 2021-01-01
• Ductal carcinoma in situ: underestimation of percutaneous biopsy and positivity of sentinel lymph node biopsy in a Brazilian public hospital.  13:409-417. 2021-01-01
• Screening a Solitary Dilated Duct in the Breast: A Pictorial Essay.  Volume 13:505-512. 2021-01-01
• The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma?.  Volume 13:45-58. 2021-01-01
• Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment.  13:31-44. 2021-01-01

• Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy

  .  Volume 12:141-151. 2020-01-01
• Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy.  12:141-151. 2020-01-01

tem uma área de assunto

• BIOTECNOLOGIA
• CIENCIAS BIOLOGICAS I
• CIENCIAS BIOLOGICAS II
• FARMACIA
• INTERDISCIPLINAR
• MEDICINA I
• SAUDE COLETIVA

publisher

• Dove Medical Press

is open access

• True invalid format

is in DOAJ

• True invalid format

2 year mean citedness

• 2.1954022988505746

H index

• 29

i10 index

• 127

ISSN-L

• 1179-1314

openalex identifier

• https://openalex.org/S4210232997

International Standard Serial Number (ISSN)

• 1179-1314

moeda do APC

• USD

valor do APC

• 2320